Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 19 | 2024 | 1045 | 1.910 |
Why?
|
| Heart Failure | 19 | 2024 | 2156 | 1.510 |
Why?
|
| Hypertension, Pulmonary | 4 | 2020 | 434 | 0.810 |
Why?
|
| Myocarditis | 1 | 2022 | 121 | 0.740 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2023 | 152 | 0.740 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 360 | 0.640 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 3 | 0.620 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 13 | 0.620 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2018 | 27 | 0.610 |
Why?
|
| Heart, Artificial | 1 | 2018 | 69 | 0.580 |
Why?
|
| Vascular Resistance | 1 | 2018 | 189 | 0.570 |
Why?
|
| Stroke Volume | 2 | 2022 | 450 | 0.570 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 462 | 0.530 |
Why?
|
| Drug Overdose | 1 | 2017 | 65 | 0.530 |
Why?
|
| Heart Transplantation | 3 | 2022 | 858 | 0.530 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 177 | 0.420 |
Why?
|
| Electrocardiography | 1 | 2017 | 967 | 0.370 |
Why?
|
| Pulmonary Artery | 3 | 2020 | 440 | 0.330 |
Why?
|
| Thrombosis | 2 | 2022 | 519 | 0.260 |
Why?
|
| Homocysteine | 1 | 2005 | 122 | 0.240 |
Why?
|
| Humans | 31 | 2024 | 124092 | 0.240 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 868 | 0.240 |
Why?
|
| Renal Dialysis | 3 | 2022 | 845 | 0.210 |
Why?
|
| Renal Replacement Therapy | 2 | 2021 | 142 | 0.200 |
Why?
|
| Retrospective Studies | 16 | 2024 | 16197 | 0.200 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2023 | 92 | 0.190 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 620 | 0.190 |
Why?
|
| Hypothermia | 1 | 2021 | 55 | 0.190 |
Why?
|
| Middle Aged | 15 | 2024 | 26320 | 0.190 |
Why?
|
| Hyponatremia | 1 | 2022 | 72 | 0.180 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2020 | 19 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2023 | 276 | 0.180 |
Why?
|
| Hypothermia, Induced | 1 | 2021 | 162 | 0.170 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 88 | 0.170 |
Why?
|
| Plasmapheresis | 1 | 2019 | 29 | 0.170 |
Why?
|
| Rivaroxaban | 1 | 2020 | 55 | 0.170 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 64 | 0.160 |
Why?
|
| Pyridones | 1 | 2020 | 112 | 0.160 |
Why?
|
| Peptide Fragments | 1 | 2023 | 750 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 234 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 227 | 0.150 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 313 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 226 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 397 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2020 | 305 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2022 | 433 | 0.140 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2019 | 122 | 0.140 |
Why?
|
| Male | 15 | 2024 | 60815 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 150 | 0.140 |
Why?
|
| Mortality | 1 | 2018 | 229 | 0.140 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 98 | 0.130 |
Why?
|
| Treatment Outcome | 9 | 2022 | 12240 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 820 | 0.130 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 498 | 0.130 |
Why?
|
| Time Factors | 4 | 2022 | 6256 | 0.130 |
Why?
|
| Patient Selection | 1 | 2018 | 687 | 0.120 |
Why?
|
| Risk Factors | 5 | 2022 | 10110 | 0.120 |
Why?
|
| Prognosis | 3 | 2021 | 4540 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 625 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 307 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2018 | 847 | 0.110 |
Why?
|
| Exercise Test | 1 | 2015 | 249 | 0.110 |
Why?
|
| Hospitalization | 2 | 2019 | 1751 | 0.110 |
Why?
|
| Acute Disease | 1 | 2017 | 1097 | 0.110 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 28 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 5087 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 1886 | 0.110 |
Why?
|
| Adult | 8 | 2022 | 29307 | 0.110 |
Why?
|
| Female | 14 | 2024 | 66165 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 211 | 0.100 |
Why?
|
| Aged | 8 | 2024 | 19352 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2012 | 40 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 233 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2886 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 440 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1103 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1016 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 162 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1813 | 0.090 |
Why?
|
| Young Adult | 3 | 2020 | 8939 | 0.090 |
Why?
|
| Incidence | 4 | 2019 | 3075 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2020 | 3045 | 0.080 |
Why?
|
| Heart | 1 | 2013 | 724 | 0.080 |
Why?
|
| Survival Rate | 3 | 2019 | 2016 | 0.080 |
Why?
|
| Equipment Design | 2 | 2021 | 609 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 633 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 838 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2022 | 581 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2017 | 6084 | 0.060 |
Why?
|
| Vitamin B 12 | 1 | 2005 | 55 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 424 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 1407 | 0.060 |
Why?
|
| Folic Acid | 1 | 2005 | 292 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 79 | 0.050 |
Why?
|
| United States | 4 | 2019 | 10740 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 268 | 0.050 |
Why?
|
| Coma | 1 | 2021 | 56 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6436 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2023 | 193 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 50 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 170 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1266 | 0.040 |
Why?
|
| Neprilysin | 1 | 2019 | 19 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2020 | 85 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 191 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 344 | 0.040 |
Why?
|
| Warfarin | 1 | 2020 | 118 | 0.040 |
Why?
|
| Quality of Life | 2 | 2021 | 1950 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1478 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 178 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2018 | 123 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 142 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1094 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 1055 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 1012 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1180 | 0.030 |
Why?
|
| Medicare | 1 | 2018 | 422 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1086 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 768 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 634 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 43 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 48 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 970 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 19272 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 823 | 0.020 |
Why?
|
| Child | 1 | 2022 | 24420 | 0.010 |
Why?
|